National, Multicentric Registry Study on Neuroimmunological Diseases in China

RecruitingOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Multiple SclerosisNMO Spectrum DisorderMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseMyasthenia GravisAutoimmune EncephalitisAcute Disseminated Encephalomyelitis
Interventions
OTHER

Data collection and follow-up observation

At the time of enrollment, the patient's biological samples are collected to obtain genetic information. Following enrollment, trained investigators carry out a 2-year follow-up observation through face-to-face, telephone call or online visits. During the follow-up, basic clinical information, laboratory tests, imaging examinations, neurophysiology, clinical classification, medication use, and scale assessments are collected.

OTHER

Data collection

Collect demographic and genetic information from healthy volunteers upon enrollment.

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital ,Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER